In Diarrhea Diarrhea is an increase in the frequency of bowel movements or loose watery bowel movements. It can most commonly occur due to an infection of the digestive tract. Kenimix SBR Powder helps to treat diarrhea that is caused due to bacteria or parasitic worm infections. Kenimix SBR Powder also contains beneficial bacteria that protect the inner layers of your stomach and intestines. This medicine can relieve frequent loose motions and also help you to stay well by preventing them from coming back. You need to take this medicine regularly to get the most out of it and you should drink plenty of fluids while taking it to make sure you stay hydrated.
It is unsafe to consume alcohol with Kenimix SBR Powder.
Kenimix SBR Powder may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Information regarding the use of Kenimix SBR Powder during breastfeeding is not available. Please consult your doctor.
Kenimix SBR Powder does not usually affect your ability to drive.
Kenimix SBR Powder should be used with caution in patients with kidney disease. Dose adjustment of Kenimix SBR Powder may be needed. Please consult your doctor. Use of Kenimix SBR Powder should be avoided in children with underlying kidney disease.
Kenimix SBR Powder should be used with caution in patients with liver disease. Dose adjustment of Kenimix SBR Powder may be needed. Please consult your doctor.
If you miss a dose of Kenimix SBR Powder, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More